
Zealand Pharma DKK 7 billion raise, Genmab FDA approval, Gubra initiates clinical development
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week was full of exciting news. The KPHC
 
															Home » Investeringscases » Sektorcases » Side 4

NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week was full of exciting news. The KPHC

All of the Nordic impact sectors declined in the past week. The CO2 & Carbon Capture only fell -0.4%, whereas the Waste Management sector saw

NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, the KPHC rose 0.7% compared to 2.5%

The Nordic impact stocks saw a mixed performance last week. The Energy Production & Storage had a good performance, while the Mobility sector had a

NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, the KPHC fell 2.2%, and the Danish

The Mobility sector is the one and only this year performing exceptionally well with a 38% return year-to-date. Clean Motion continues with very strong momentum

NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, the KPHC rose 1.6%, and the Danish

In the past week, the majority of impact sectors delivered a positive with the Mobility sector as the best performer. As always, there are interesting

NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, the KPHC rose 3.8%, while the Danish

In the past week, all of the impact sectors delivered a positive return – for the first time! Especially the Power2X & Fuel Cells sector
Kapital Partner udfører eller har inden for de seneste 12 måneder udført corporate finance, market relations, investor relations, Certified Adviser eller andre rådgivningsaktiviteter for følgende børsnoterede selskaber: CS Medica, EKOBOT AB, Biotech, Ensurge, Lifecare AS, NORD.investments, Biosergen, Hypefactors, Curasight, Re-Match, Mdundo.com, Nexcom.
 
															
Del indlægget på sociale media eller på email.